(S (NP (NP (NN Cardiotoxicity)) (VP (VBN related) (PP (IN to) (NP (NN cancer) (NNS therapies))))) (VP (VBZ has) (VP (VBN become) (NP (DT a) (JJ serious) (NN issue)) (, ,) (S (VP (VBG diminishing) (NP (NP (NML (NN cancer) (NN treatment)) (NNS outcomes)) (CC and) (NP (NP (NN quality)) (PP (IN of) (NP (NN life))))))))) (. .))
(S (UCP (ADVP (RB Early) (NP (NP (NN detection)) (PP (IN of) (NP (NN cancer) (NNS patients)))) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (NN cardiotoxicity))))) (PP (IN before) (NP (JJ cardiotoxic) (NNS treatments)))) (CC and) (VP (VBG providing))) (NP (JJ preventive) (NNS measures)) (VP (VBP are) (NP (JJ potential) (NNS solutions) (S (VP (TO to) (VP (VB improve) (NP (NP (NP (NN cancer) (NNS patients) (POS 's)) (NN quality)) (PP (IN of) (NP (NN life))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ focuses) (PP (IN on) (S (VP (VBG predicting) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN heart) (NN failure)))) (PP (IN in) (NP (NN cancer) (NNS patients))) (PP (IN after) (NP (NP (NN cancer) (NNS diagnoses)) (VP (VBG using) (NP (JJ historical) (NML (NML (JJ electronic) (NN health) (NN record)) (-LRB- -LRB-) (NML (NN EHR)) (-RRB- -RRB-)) (NNS data))))))))) (. .))
(S (NP (PRP We)) (VP (VBD examined) (NP (CD four) (NML (NN machine) (NN learning)) (NNS algorithms)) (S (VP (VBG using) (NP (CD 143,199) (NN cancer) (NNS patients)) (PP (IN from) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Florida) (NNP Health) (-LRB- -LRB-) (NML (NNP UF) (NNP Health)) (-RRB- -RRB-) (NNP Integrated) (NNP Data) (NNP Repository) (PRN (-LRB- -LRB-) (NP (NNP IDR)) (-RRB- -RRB-))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD identified) (NP (NP (DT a) (JJ total) (NN number)) (PP (IN of) (NP (CD 1,958) (JJ qualified) (NNS cases))))) (CC and) (VP (VBD matched) (NP (PRP them)) (PP (IN to) (NP (CD 15,488) (NNS controls))) (PP (IN by) (NP (NN gender) (, ,) (NN age) (, ,) (NN race) (, ,) (CC and) (JJ major) (NN cancer) (NN type))))) (. .))
(S (NP (NP (CD Two) (NN feature)) (VP (VBG encoding) (NP (NNS strategies)))) (VP (VBD were) (VP (VBN compared) (S (VP (TO to) (VP (VB encode) (NP (NNS variables)) (PP (IN as) (NP (NML (NN machine) (NN learning)) (NNS features)))))))) (. .))
(S (NP (NP (DT The) (NN gradient)) (VP (VBG boosting) (NP (NP (-LRB- -LRB-) (NN GB) (-RRB- -RRB-)) (VP (VBN based) (NP (NN model)))))) (VP (VBD achieved) (NP (NP (DT the) (JJS best) (NN AUC) (NN score)) (PP (IN of) (NP (NP (CD 0.9077)) (-LRB- -LRB-) (PP (IN with) (NP (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 0.8520)))) (CC and) (NP (NP (DT a) (NN specificity)) (PP (IN of) (NP (CD 0.8138)))))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG outperforming) (NP (JJ other) (NML (NN machine) (NN learning)) (NNS methods))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VP (VBD looked) (PP (IN into) (NP (NP (DT the) (NN subgroup)) (PP (IN of) (NP (NN cancer) (NNS patients))))) (PP (IN with) (NP (NN exposure))) (PP (IN to) (NP (NN chemotherapy) (NNS drugs)))) (CC and) (VP (VBD observed) (NP (DT a) (JJR lower) (NN specificity) (NN score))) (PRN (-LRB- -LRB-) (NP (CD 0.7089)) (-RRB- -RRB-))) (. .))
(S (NP (DT The) (JJ experimental) (NNS results)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NML (NN machine) (NN learning)) (NNS methods)) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB capture) (NP (NP (JJ clinical) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NN heart) (NN failure))))))))))))))))))) (CC and) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ feasible) (S (VP (TO to) (VP (VB use) (NP (NML (NN machine) (NN learning)) (NNS methods)) (S (VP (TO to) (VP (VB identify) (NP (NN cancer) (NNS patients)) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (ADJP (NP (NN cancer) (NN therapy)) (HYPH -) (VBN related)) (NN heart) (NN failure))))))))))))))))) (. .))
